PPIST16213

Protein Information
Protein_Chain A; C/B; D
Protein_Sequence IKEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALANIAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWLRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFDAPSPLPETTEV/DTRPRFLEQVKHECHFFNGTERVRFLDRYFYHQEEYVRFDSDVGEYRAVTELGRPDAEYWNSQKDLLEQKRAAVDTYCRHNYGVGESFTVQRRVYPEVTVYPAKTQPLQHHNLLVCSVNGFYPGSIEVRWFRNGQEEKTGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSLTSPLTVEWRARSESAQSKV
Peptide Information
Peptide_Chain E[auth G]; F[auth H]
Peptide_Sequence AFAPVSKMRMATPLLMQAGN
Peptide_Length 20
Non-standard residues No
Interaction Information
PDB_ID 7YXB
Method X-RAY DIFFRACTION
Resolution 2.10 angstrom
Structure
Protein-peptide residue interaction
Residues
Acidic
Polar
Basic
Aliphatic
Aromatic
Interactions
HBond
WaterBridge
Hydrophobic
SaltBridge
PiStack
PiCation
Halogen
Metal
Interaction_xlsx Download interaction table (.xlsx)
Reference Information
Title MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange.
Release_Year 2023
PMID 37142807
DOI 10.1038/s41589-023-01316-3